esbl double disc test & dcdt esbl esbl · caz/cv cn p/ mdr dcdt esbl esbl esbl esbl esbl p/ /....
TRANSCRIPT
/
smansouri @ kmu.ac.ir
ESBL
ESBLDCDTdouble disc test &
combined disc test
ESBL
ESBL
Extended Spectrum -Lactamases: ESBLs
ESBL
EMBc
TSIOF
ONPGDNase
TSB
g/ml
g/mlMAST
Minimum
Inhibitory concentration: MIC
CLSI
(MAST)
comcombined disc
double disc test+ combined disc)(DCDT:
DCDT
MAST
ESBL
ATCC ATCC
KOAS
PER-1 TEM
.
SPSS=18
(Chi-square)
/P
(MIC)
MIC(µg/ml)
ESBL
Ac CTXCAZCPDCPM
CNCAZ/CV
/P
MDR
DCDT
ESBL
ESBL
ESBL
ESBL
ESBL
/P
/
.
Giske
MDR
/P
Malini
AbaR1
L1
L1
L2
Aibinu
Al-NaiemiDCDT
ESBL
ESBL
ESBL
ESBL
MIC
ESBL
ESBL(P 0.01)
MDR
MDR
ESBL
1.Clinical and Laboratory Standards Institute. Methods for dilution antimicrobials susceptibility tests for bacteria that grow aerobically. Approved standard 6th edition.CLSI document M7-A7. Wayne,PA.2006. 2. Malini A, Deepa EK, Gokul BN , Prasad SR. Nonfermenting gram negative bacilli infections in a tertiary care hospital in Kolar, Karnataka. J Lab Physicians 2009:1(2):62-66.
3. Quinn JP. Clinical problems posed by multi resistant non fermenting gram negative pathogens. Clin Infect Dis 1998;27(Suppl 1):S117-S124. 4. Vidal F, Mensa J, Almela M, Olona M, Martinez JA, Marco F, et al. Bacteremia in adults due to glucose non-fermentative gram-negative bacilli other than P.aeruginosa QJMed.2003;96:227-234.
5. Mc Gowan JE Jr. Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum. Am J Med 2006; 119(6A):S29-S36. 6.Higgins CS, Murtough SM, Williamson E. Resistance to antibiotics and biocides among non-fermenting gram- negative bacteria. Clin Microbiol Infect 2001;7:308-315. 7. Paterson DL, Bonomo RA. Extended-Spectrum -lactamases:a clinical update. Clin Microbiol Rev 2005;18(4):657-686. 8. Al Naiemi N, Duim B, Bart A. A CTX-M Extended-spectrum -lactamases in Pseudomonas aeruginosa and Stenotrophomonas maltophilia . .J Med Microbiol 2006;55:1607-1608. 9. Al Naiemi N, Bart A, De Jong MD, Vondenbrouck-Grauls CM, Rietra PJGM, Debets-Ossenkopp YJ ,et al. Widely distributed and predominant CTX-M extended-spectrum -lactamases in Amsterdam,the Netherlands. J Clin Micrbiol 2006;44(8):3012-3014. 10. Shakibaei MR, Shahcheraghi F, Hashemi A, Saeed Adeli N. Detection of TEM, SHV and PER type extended-spectrum -lactamases genes among clinical strains of Pseudomonas aeruginosa isolated from burnt patients at Shafa- Hospital,Kerman, Iran. Iran J Basic Med Sci 2008; 11(2):104-111. 11. Harley JP, Prescott LM. Laboratory exercises in microbiology. 5th ed . New York; Mc Graw-Hill . 2006 ; pp: 83-89 12. Uzunova T, Donev T. Anabiosis and conservation of microorganisms. J Cult Collection . 2005;4(1):14-28. 13. Lorian V. Antibiotics in laboratory medicine . 5th ed. Baltimore; Williams & Wilkins.2005;PP:114-120. 14. Giske CG, Monnet DL, Cars O, Carmeli Y. Clinical and economic
impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother. 2008;52(3):813-821.
16. Ekrami A, Kalantar E. Bacterial infections in burn patients in at a burn hospital in Iran. Indian J Med Res 2007;126:541-544. 17.Maragakis LL, Perl TM.Acinetobacterbaumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect . Dis 2008; 46:1254-1263. 18. Fournier PE ,Vallenet D, Barbe V, Audic C, Ogata H, Poirel L.Comparative genomics of multidrug resistance in Acinetobacter baumannii.PLOS Gen. 2006;2(1): 0062- 0071. 19. Avison MB, Higgins CS, Ford PJ, Von Heldreich CJ, Walsh TR, Bennett PM, et al. Differential regulation of L1,L2 beta-lactamase expression in Stenotrophomonas maltophilia. J Antimicrob Chemother 2002;49(2):387-389. 20. Aibinu A, Nwanneka T, Odugbemi T. Occurrence of extended-spectrum -lactamase and MBL in clinical isolates of Pseudomonas aeruginosa from Lagos,Nigeria. J Am Sci. 2007;3(4):81-85. 21.Pool K.Efflux-mediated multi resistance in Gram-Negative bacteria .Clin Microbiol. Infect 2004;10(1):12-26.